HIV/AIDS

8.1 Prevention, screening and management of common coinfections

Consolidated ARV guidelines, June 2013

8.1.1 Co-trimoxazole preventive therapy

Background

Co-trimoxazole preventive therapy (CPT) should be implemented as an integral component of a package of HIV-related services. Existing recommendations cover initiation of co-trimoxazole preventive therapy among adults, adolescents, pregnant women and children for prevention of Pneumocystis pneumonia, toxoplasmosis and bacterial infections, as well as benefits for malaria prophylaxis and discontinuation of cotrimoxazole preventive therapy.

Source of recommendations

These recommendations will be updated in 2014.

Key selected existing recommendations

Table 8.1 shows the recommendations. Refer to the Web Annex for methodology used in rating the quality of evidence.

Share